$CTEV

Mintz William B. sold $289K of CTEV

Mintz William B. (SVP, Chief Strategy Officer) sold 8,431 shares of Claritev Corp (CTEV) at $34.24 ($0.29M total) on 2026-08-10.

Original reporting
SEC EDGAR · Mintz William B.
Published Aug 12, 2026, 8:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CTEV
Neutral
medium confidence
Mentioned
$CTEV
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTEVNeutralLow
01

Why it matters

The newest fact is the Aug 10 open-market sale of 8,431 shares by an SVP, filed Aug 12. The disclosure alone does not include any operational or financial update.

02

Market read

Traders may monitor for patterns in insider activity, but this single sale provides limited actionable information.

03

What to watch

Insider sales are often diversification or liquidity-driven; without additional context (e.g., grants, options exercises, or repeated sales), the signal is weak.

Relevance 4/10Novelty 3/10Timing: filed Aug 12, transaction dated Aug 10

Background

The article is an SEC Form 4 insider transaction disclosure for Claritev Corp (CTEV).

Company-level read

Ticker impact

$CTEVNeutralMedium confidence
Context

Claritev (CTEV) disclosed an insider open-market sale by SVP Chief Strategy Officer William B. Mintz of 8,431 shares at $34.24.

Expected impact

Likely minimal near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The filing is a single insider sale with disclosed price and size, but the article provides no accompanying company news, guidance, or legal/regulatory catalyst.

Market effects

No sector-level signal; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Absence of a stated 10b5-1 plan can be interpreted by some traders as less mechanical selling, potentially adding short-term bearish sentiment.

Key entities

  • Claritev Corp

    Company that filed the Form 4 insider transaction disclosure.

  • William B. Mintz

    SVP, Chief Strategy Officer who sold shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTEVMedAI 8/10

Claritev Q2 Earnings Call Highlights

Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.

$CTEVMed

Claritev Corp (CTEV): Results of Operations and Financial Condition

Claritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202